小儿七星茶口服液与保和口服液对照治疗小儿积滞乳食内积证的临床研究
|
摘要
目的:评价小儿七星茶口服液治疗小儿积滞乳食内积证(消化功能紊乱症)的有效性与安全性。方法:采用分层区组随机、双盲、阳性药平行对照、多中心、双侧差异性检验临床研究方法。结果:小儿七星茶口服液治疗小儿积滞乳食内积证(消化功能紊乱症),对主症不思饮食、大便不畅、夜寐不安的总有效率,优效性检验结果,试验药物组不劣于阳性药对照组,对中医证候的总有效率,试验药物组为96.23%,阳性药对照组为88.68%,差异有显著统计学意义,试验药物组优于阳性药对照组;两组在脘腹胀痛、舌质舌苔改善方面治疗前后有显著统计学意义,试验药物组优于阳性药对照组。试验中,试验药物组出现不良事件3例,阳性药对照组出现不良事件4例,不良事件/反应发生率比较,差异无统计学意义。结论:小儿七星茶口服液对小儿积滞乳食内积证(消化功能紊乱症)治疗效果优于对照药保和口服液,且临床应用较为安全。
Objective: To evaluate the efficacy and safety of Xiao'er Qixingcha oral liquid treating pediatric stagnation food accumulation syndrome( digestive function disorder). Methods: The stratified blocked randomization,double blind,positive parallel control,multi-center,bilateral difference test clinical research methods were used. Results: Xiao'er Qixingcha oral liquid treating pediatric stagnation food accumulation syndrome( digestive function disorder) had effective rates of main symptom and the trial group was not inferior to the control group. The total effective rate of TCM syndrome in the trial group was 96. 23% and that of the control group was 88. 68%. There was significant difference. The trial group was better than the control group. The two groups in terms of abdominal distension and tongue coating had significant statistical significance before and after the treatment and the trail group was better than the control group. In trials,the trial group appearred adverse events( 3 cases) and control group had 4 cases of adverse events. The incidence of adverse events / reaction in two groups had no statistically significant difference. Conclusion:The therapeutic efficacy of Xiao'er Qixingcha oral liquid treating pediatric stagnation food accumulation syndrome( digestive function disorder) is better and the clinical application of safer.
Objective: To evaluate the efficacy and safety of Xiao'er Qixingcha oral liquid treating pediatric stagnation food accumulation syndrome( digestive function disorder). Methods: The stratified blocked randomization,double blind,positive parallel control,multi-center,bilateral difference test clinical research methods were used. Results: Xiao'er Qixingcha oral liquid treating pediatric stagnation food accumulation syndrome( digestive function disorder) had effective rates of main symptom and the trial group was not inferior to the control group. The total effective rate of TCM syndrome in the trial group was 96. 23% and that of the control group was 88. 68%. There was significant difference. The trial group was better than the control group. The two groups in terms of abdominal distension and tongue coating had significant statistical significance before and after the treatment and the trail group was better than the control group. In trials,the trial group appearred adverse events( 3 cases) and control group had 4 cases of adverse events. The incidence of adverse events / reaction in two groups had no statistically significant difference. Conclusion:The therapeutic efficacy of Xiao'er Qixingcha oral liquid treating pediatric stagnation food accumulation syndrome( digestive function disorder) is better and the clinical application of safer.
引文
[1]吴瑞萍,胡亚美,江载芳.诸福棠实用儿科学[M].第7版,北京:人民卫生出版社,2002:3.
[2]徐荣谦.中医儿科学[M].第1版.北京:中国中医药出版社,2010.
[3]国家中医药管理局.中医病证诊断疗效标准[M].南京:南京大学出版社,1994.
[4]汪受传.中医儿科学[M].第1版.北京:中国中医药出版社,2002.
[5]熊欣,黄伟,王雪峰.王雪峰教授运用清热化滞疗法治疗小儿积滞的经验[J].中国中西医结合儿科学,2013,(2):99.
[6]冯海音,徐荣谦,徐荣谦.教授“从胆论治”小儿积滞经验[J].中国中西医结合儿科学,2013,(2):99.
[7]李晓倩,赵霞.脾胃虚寒与小儿积滞关系探讨[J].辽宁中医药大学学报,2011,(9):43.
[8]韩谨.周耀庭教授运用导滞十法治疗儿科疾病的经验[A]//第二十五届全国中西医结合消化系统疾病学术会议论文集[C].2013.
[9]张贵春,史正刚.史正刚教授运用曲麦枳术丸治疗小儿积滞的经验[J].中医儿科杂志,2010,(4):1-2.
[10]许双虹,陈建宏,林诗书.小儿七星茶新用[J].新中医,2009,(3):100.
[2]徐荣谦.中医儿科学[M].第1版.北京:中国中医药出版社,2010.
[3]国家中医药管理局.中医病证诊断疗效标准[M].南京:南京大学出版社,1994.
[4]汪受传.中医儿科学[M].第1版.北京:中国中医药出版社,2002.
[5]熊欣,黄伟,王雪峰.王雪峰教授运用清热化滞疗法治疗小儿积滞的经验[J].中国中西医结合儿科学,2013,(2):99.
[6]冯海音,徐荣谦,徐荣谦.教授“从胆论治”小儿积滞经验[J].中国中西医结合儿科学,2013,(2):99.
[7]李晓倩,赵霞.脾胃虚寒与小儿积滞关系探讨[J].辽宁中医药大学学报,2011,(9):43.
[8]韩谨.周耀庭教授运用导滞十法治疗儿科疾病的经验[A]//第二十五届全国中西医结合消化系统疾病学术会议论文集[C].2013.
[9]张贵春,史正刚.史正刚教授运用曲麦枳术丸治疗小儿积滞的经验[J].中医儿科杂志,2010,(4):1-2.
[10]许双虹,陈建宏,林诗书.小儿七星茶新用[J].新中医,2009,(3):100.